3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Renal Cell
3
Recurrence
2
Neoplasm Metastasis
2
Melanoma
2
Kidney Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Solid Tumors
1
Solid Tumor
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Metastatic Urothelial Cancer
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Cisplatin
13
pembrolizumab
10
Radiotherapy, Intensity-Modulated
9
Carboplatin
9
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Cetuximab
7
Radiotherapy
5
Radiation
5
Paclitaxel
5
Biopsy
5
Taxes
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Docetaxel
3
ipatasertib
2
durvalumab
2
X-Rays
2
Surgical Procedures, Operative
2
Standard of Care
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Disulfides
2
Chemoradiotherapy
2
trametinib
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
zimberelimab
×
1 year
×
Clear all
No trials found.